Business Description
Eli Lilly and Co
NAICS : 325412
SIC : 2834
ISIN : US5324571083
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 2.19 | |||||
Debt-to-EBITDA | 2.49 | |||||
Interest Coverage | 21.8 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 8.38 | |||||
Beneish M-Score | -1.9 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | -1 | |||||
3-Year EPS without NRI Growth Rate | -7.3 | |||||
3-Year Book Growth Rate | 26.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 68.09 | |||||
Future 3-5Y Total Revenue Growth Rate | 27.64 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.66 | |||||
9-Day RSI | 53.01 | |||||
14-Day RSI | 49.69 | |||||
6-1 Month Momentum % | -4.6 | |||||
12-1 Month Momentum % | 58.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 287.39 | |||||
Days Sales Outstanding | 83.01 | |||||
Days Payable | 124.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.61 | |||||
Dividend Payout Ratio | 0.5 | |||||
3-Year Dividend Growth Rate | 15.2 | |||||
Forward Dividend Yield % | 0.75 | |||||
5-Year Yield-on-Cost % | 1.23 | |||||
3-Year Average Share Buyback Ratio | 2 | |||||
Shareholder Yield % | -0.67 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.91 | |||||
Operating Margin % | 37.02 | |||||
Net Margin % | 20.48 | |||||
FCF Margin % | -5.45 | |||||
ROE % | 66.85 | |||||
ROA % | 12.55 | |||||
ROIC % | 24.99 | |||||
ROC (Joel Greenblatt) % | 68.24 | |||||
ROCE % | 25.38 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 89.65 | |||||
Forward PE Ratio | 35.27 | |||||
PE Ratio without NRI | 81.55 | |||||
Shiller PE Ratio | 140.96 | |||||
PEG Ratio | 7.62 | |||||
PS Ratio | 18.36 | |||||
PB Ratio | 52.41 | |||||
Price-to-Tangible-Book | 385.76 | |||||
Price-to-Operating-Cash-Flow | 124.41 | |||||
EV-to-EBIT | 68.51 | |||||
EV-to-Forward-EBIT | 30.51 | |||||
EV-to-EBITDA | 59.38 | |||||
EV-to-Forward-EBITDA | 28.6 | |||||
EV-to-Revenue | 18.18 | |||||
EV-to-Forward-Revenue | 12.75 | |||||
EV-to-FCF | -315.62 | |||||
Price-to-Projected-FCF | 14.4 | |||||
Price-to-Median-PS-Value | 3.11 | |||||
Price-to-Peter-Lynch-Fair-Value | 10.3 | |||||
Price-to-Graham-Number | 37.39 | |||||
Earnings Yield (Greenblatt) % | 1.46 | |||||
FCF Yield % | -0.31 | |||||
Forward Rate of Return (Yacktman) % | 8.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Eli Lilly and Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 737,657.382 | ||
EPS (TTM) (MXN) | 163.84 | ||
Beta | -0.22 | ||
Volatility % | 39.54 | ||
14-Day RSI | 49.69 | ||
14-Day ATR (MXN) | 330.50598 | ||
20-Day SMA (MXN) | 16123.803 | ||
12-1 Month Momentum % | 58.19 | ||
52-Week Range (MXN) | 9532.52 - 19261 | ||
Shares Outstanding (Mil) | 899.32 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Eli Lilly and Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Eli Lilly and Co Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Eli Lilly and Co Frequently Asked Questions
What is Eli Lilly and Co(MEX:LLY)'s stock price today?
When is next earnings date of Eli Lilly and Co(MEX:LLY)?
Does Eli Lilly and Co(MEX:LLY) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |